HDAC9 and neoplasm: Tumour regression induced by the pan-HDAC inhibitor panobinostat in mice is dependent on the presence of natural killer (NK) cells [27] and HDAC inhibitors improved the efficacy of anti-CD20-based therapeutics, including monoclonal antibodies, by enhancing the expression of CD20 [28, 29].